PMID: 9192396May 1, 1997Paper

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach

Obesity Research
T A WaddenG D Foster

Abstract

This study examined a new method of providing brief, individual lifestyle modification to obese individuals treated by pharmacotherapy. Twenty-six women with a mean (+/- SD) age of 47.0 +/- 7.2 years, weight of 97.6 +/- 13.0 kg, and body mass index of 36.5 +/- 5.0 kg/m2 were prescribed 60 mg/d of fenfluramine and 15 mg/d of phentermine for one year. In addition, half of the women were randomly assigned to traditional group behavior modification, conducted by a nutritionist, which included 32 75-minute sessions during the year. The other half were provided lifestyle modification by a physician during 10 15-20 minute structured visits. All participants received identical treatment manuals and comparable assignments for behavior change. At the end of one year, patients in the physician group achieved the same highly successful weight losses as those treated by group behavior modification (13.9 +/- 9.6 kg vs. 15.4 +/- 7.9 kg, respectively). Treatment was associated with highly significant improvements in lipids and lipoproteins, as well as in mood and several measures of appetite. Weight loss the first four weeks, as well as patient completion of daily food records during the first 18 weeks, correlated positively with weight loss a...Continue Reading

References

Apr 1, 1992·The American Journal of Clinical Nutrition·G D FosterA M Conill
May 1, 1992·Clinical Pharmacology and Therapeutics·M WeintraubB Schuster
Jul 1, 1992·The American Journal of Clinical Nutrition·R L WeinsierA A Bartolucci
Nov 11, 1989·Lancet·B Guy-GrandP Turner
Jan 1, 1988·Addictive Behaviors·D G Schlundt, R T Zimering
Apr 1, 1984·Journal of Consulting and Clinical Psychology·Linda Wilcoxon Craighead
Jun 14, 1982·Life Sciences·A J Stunkard
Jul 1, 1981·Archives of General Psychiatry·L W CraigheadR M O'Brien
Aug 1, 1995·The American Journal of Clinical Nutrition·R E AndersenR S Weinstock
Nov 1, 1994·The American Journal of Clinical Nutrition·D J Goldstein, J H Potvin
Oct 1, 1993·Annals of Internal Medicine·G A Bray
Sep 1, 1995·Obesity Research·G Blackburn
Mar 1, 1996·The American Journal of Clinical Nutrition·T A WaddenG D Foster
Aug 29, 1996·The New England Journal of Medicine·J E Manson, G A Faich
Nov 1, 1995·Obesity Research·R L AtkinsonR A Lutes
May 1, 1996·Obesity Research·G A BrayK Wilson

❮ Previous
Next ❯

Citations

Sep 25, 2010·Maternal and Child Health Journal·Alma D GuerreroAlice A Kuo
Aug 11, 2000·General Hospital Psychiatry·A I GreenG Blackburn
Mar 4, 2000·Clinical Cornerstone·K D Brownell
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J D Latner
Nov 18, 2005·The New England Journal of Medicine·Thomas A WaddenAlbert J Stunkard
Jan 6, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Marjorie R Freedman, Judith S Stern
Jun 6, 2000·Journal of Women's Health & Gender-based Medicine·D B Sarwer, T A Wadden
Sep 24, 2013·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Beatriz De-Mateo-SillerasAlberto Miján-de-la-Torre
Jul 31, 2003·American Journal of Respiratory and Critical Care Medicine·Gary D Foster
Jul 20, 2005·Treatments in Endocrinology·Hans Hauner
Dec 3, 2003·Eating and Weight Disorders : EWD·N MelchiondaG Marchesini
Aug 15, 2014·American Journal of Public Health·François ModaveNorma Nguyen
Sep 6, 2002·Journal of General Internal Medicine·Martin Binks, Mahlen Patrick O'Neil
Aug 18, 2006·Journal of the American Pharmacists Association : JAPhA·Dannielle C O'DonnellHoma B Dastani
Dec 1, 2009·Appetite·Riccardo Dalle GraveUNKNOWN QUOVADIS Study Group
Jul 2, 2004·Obesity Research·Leslie G WombleE Stephanie Krauthamer-Ewing
Nov 27, 2004·Journal of the American Dietetic Association·Cynthia ChengJames J Diamond
Jun 6, 2009·Behaviour Research and Therapy·Anthony N FabricatoreAllison Martin Nguyen
Apr 28, 2009·Autoimmunity Reviews·Paul J AlbertTrevor G Marshall
May 20, 2005·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Simone MunschSandra Roth
Feb 19, 2013·American Journal of Preventive Medicine·Javier I RosadoJordan P Cuevas
Aug 4, 1998·Obesity Research·T A WaddenJ L Aber
Jun 11, 2002·Obesity Research·Suzanne Phelan, Thomas A Wadden
Sep 24, 2004·The Annals of Pharmacotherapy·Homa B DastaniDannielle C O'Donnell
Mar 25, 2005·The British Journal of Nutrition·Vicky DrapeauAngelo Tremblay
May 13, 2003·Clinical Pediatrics·Elissa JelalianRachel Frank
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Sophie DesrochesStéphane Turcotte
Jan 28, 2005·The Cochrane Database of Systematic Reviews·S L NorrisJ Lau
Jul 2, 2005·Journal of Psychiatric Practice·J H Gold
Jun 25, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·V DrapeauA Tremblay
May 6, 1998·Obesity Research·J P Foreyt, W S Poston
Oct 17, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·J Michael Gonzalez-CampoyUNKNOWN American College of Endocrinology and the Obesity Society
Aug 21, 2019·Creative Nursing·Trina Lorraine Gipson-JonesChé Matthew Harris
Jul 20, 2007·The Cochrane Database of Systematic Reviews·M J H HuibersC P van Schayck
Feb 18, 2018·BMJ Open·Elizabeth A SturgissKirsty A Douglas
Jun 22, 2011·Expert Opinion on Pharmacotherapy·Sonja K Billes, Frank L Greenway
May 22, 2007·International Journal of Behavioral Medicine·Lisbeth StahreTore Hällström

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.